INS and gestational diabetes: FABP4 promoter has a binding site for insulin, fatty acids, and hypoxia-inducible factor [60,61], and these are all increased in GDM conditions [45,62,63], possibly contributing to FABP3 and FABP4 promoter activation and upregulation.